Topical drug classification

被引:51
|
作者
Buhse, L
Kolinski, R
Westenberger, B
Wokovich, A
Spencer, J
Chen, CW
Turujman, S
Gautam-Basak, M
Kang, GJ
Kibbe, A
Heintzelman, B
Wolfgang, E
机构
[1] FDA, Div Pharmaceut Anal, Off Pharmaceut Sci, Ctr Drug Evaluat & Res, St Louis, MO 63101 USA
[2] US FDA, CDER, OPS, Off New Drug Chem, Rockville, MD USA
[3] Wilkes Univ, Wilkes Barre, PA USA
关键词
ointment; cream; gel; lotion; topical drug;
D O I
10.1016/j.ijpharm.2005.01.032
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Current definitions of lotions, gels, creams and ointments vary depending on literature source, market history or traditional use. This often leads to confusion when deciding which dosage form to prescribe and/or purchase. The existing classification of topical dosage forms needs to be re-examined to ensure that definitions for different dosage forms are based on consistent scientific principles and that dosage forms can be distinguished from one another. The purpose of this study is to obtain a scientifically based, systematic classification of dosage forms for topical drugs. A variety of prescription and over-the-counter topical products Currently marketed as lotions, gels, creams, and ointments are evaluated using different techniques including rheology (viscosity and shear rate versus shear stress), loss on drying (LOD), specific gravity, surface tension, thermogravimetric analysis (TGA), water absorption, dilution properties, microscopic evaluation, transmittance of visible light, appearance and composition. Rheology is the most discriminating property separating creams and lotions. Water plus volatiles (as measured by LOD) and composition separate ointments and creams. Composition and thermal behavior separate gels from the other dosage forms. Based on these findings, new definitions and a decision tree are presented to assist in the determination of the appropriate nomenclature for a topical dosage form. © 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:101 / 112
页数:12
相关论文
共 50 条
  • [21] Fnnovative drug carriers for topical therapy
    Borgia, SL
    Stecova, J
    Schlupp, P
    Mehnert, W
    Korting, BC
    Danker, K
    Schäfer-Korting, MS
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R92 - R92
  • [22] A troubleshooting guide for topical drug manufacturing
    Lowenborg, Michael
    Pharmaceutical Technology, 2012, 36 (11) : 46 - 50
  • [23] A NEW TOPICAL ANTIFUNGAL DRUG - TIOCONAZOLE
    VANDERPLOEG, DE
    DEVILLEZ, RL
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1984, 23 (10) : 681 - 683
  • [24] LIPOSOMES AS A TOPICAL DRUG DELIVERY SYSTEM
    EGBARIA, K
    WEINER, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 14 - PMSE
  • [25] ELECTROSPUN NANOFIBERS FOR TOPICAL DRUG DELIVERY
    Wagner, I.
    Pataki, H.
    Balogh, A.
    Nagy, Zs. K.
    Harasztos, A. H.
    Suhajda, A.
    Marosi, Gy.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 44 : 148 - 149
  • [26] Evaluation of topical drug treatment in psoriasis
    van de Kerkhof, PCM
    Steegers-Theunissen, RPM
    Kuipers, MV
    DERMATOLOGY, 1998, 197 (01) : 31 - 36
  • [27] Topical drug therapeutics for neuropathic pain
    Coderre, Terence J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (11) : 1211 - 1220
  • [28] Topical drug delivery devices: A review
    Bertens, Christian J. F.
    Gijs, Marlies
    van den Biggelaar, Frank J. H. M.
    Nuijts, Rudy M. M. A.
    EXPERIMENTAL EYE RESEARCH, 2018, 168 : 149 - 160
  • [29] MICROSPONGES: AS A TOPICAL DRUG DELIVERY SYSTEM
    Sharma, Shailesh
    Sharma, Anu
    Kaur, Chamanpreet
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (02): : 524 - 534
  • [30] MICONAZOLE - NEW TOPICAL ANTIFUNGAL DRUG
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1974, 16 (24): : 97 - 98